Spectrum Pharmaceuticals, Inc. SPPI -26% - Received unfavorable litigation ruling in Fusilev case.
Cyberark Software Ltd CYBR -5% - Downgraded to Underweight at JP Morgan.
Rigel Pharmaceuticals, Inc. RIGL +45% - Reported research collaboration with Bristol-Myers Squibb.
Biocept Inc BIOC +27% - Announced favorable findings from OncoCEE-BR Study.
Ballard Power Systems Inc. (USA) BLDP +16% - Signed two new technology contracts.
Polypore International, Inc. PPO +13% - Polypore’s media business will be acquired by 3M for $1 billion.
Celldex Therapeutics, Inc. CLDX +14.5% - Received breakthrough designation from FDA for its Rintega therapy.
ADMA Biologics Inc ADMA +5% - Reported positive data from phase III RI-002 trial.
Home Loan Servicing Solutions Ltd HLSS +8% - New Residential will acquire HLSS for $18.25 per share.
Tower Semiconductor Ltd. (USA) TSEM +8.7% - Announced Q4 EPS.
Valeant Pharmaceuticals Intl Inc VRX +9% - Announced purchase of Salix Pharmaceuticals for ~$10 billion.
Ocwen Financial Corp OCN +2.6% - Announced intent to sell $9.8 billion in assets.
Pacific Drilling SA PACD +4.3% - Reported Q4 EPS.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
